治験
Clinical trials of Epanova for severe hypertriglyceridemia showed good results. However, a clinical trial on mixed dyslipidaemia (hypertriglyceridemia with hypocholesterolemia) was started on 30 October 2014, which after phase III, was terminated on 13 January 2019 due to lack of medical benefit in the results.